The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel integrin-targeted, zwitterionic imaging agent, for margin detection of pancreatic ...

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...

When Apellis Pharmaceuticals (APLS) secured FDA approval for EMPAVELI in C3 glomerulopathy and IC-MPGN last summer, the stock ...

Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.

The FDA is currently reviewing the compatibility of the Simplera sensor with the MiniMed Go system.

Intensity Therapeutics, Inc. ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the ...

Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026 SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- ...

Managing diabetes is a full-time job. But, AI tools are making insulin dosing, glucose tracking, and everyday care a little ...